{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:00:17Z","timestamp":1790085617494,"version":"4.0.1"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009331","name":"Clinical Medicine Development of Special Funding Support of Beijing Municipal Hospital Management Center","doi-asserted-by":"publisher","award":["YGLX202508"],"award-info":[{"award-number":["YGLX202508"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119847","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:45:53Z","timestamp":1787219153000},"page":"119847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The apelin\/APJ signaling axis in ocular neurovascular disorders: Molecular mechanisms and therapeutic strategies for angiogenesis and neurodegeneration"],"prefix":"10.1016","volume":"203","author":[{"given":"Sihan","family":"Sang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7658-9865","authenticated-orcid":false,"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2026.119847_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","article-title":"Current understanding of the molecular and cellular pathology of diabetic retinopathy","volume":"17","author":"Antonetti","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119847_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/dmcn.15468","article-title":"Retinopathy of prematurity","volume":"65","author":"Dammann","year":"2023","journal-title":"Dev. Med. Child. Neurol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119847_bib3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119847_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2024.102967","article-title":"Global Prevalence and Severity of Retinopathy of Prematurity over the Last Four Decades (1985-2021): A Systematic Review and Meta-Analysis","volume":"55","author":"Garcia","year":"2024","journal-title":"Arch. Med. Res."},{"issue":"7","key":"10.1016\/j.biopha.2026.119847_bib5","doi-asserted-by":"crossref","first-page":"e1175","DOI":"10.1016\/S2214-109X(25)00143-3","article-title":"Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"13","author":"GBD 2021 Global AMD Collaborators","year":"2025","journal-title":"Lancet Glob. Health"},{"issue":"7","key":"10.1016\/j.biopha.2026.119847_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond. )"},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2023.12.026","article-title":"Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials","volume":"131","author":"Wong","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2026.119847_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2022.170767","article-title":"Multiple roles of apelin\/APJ system in eye diseases","volume":"152","author":"Luo","year":"2022","journal-title":"Peptides"},{"issue":"23","key":"10.1016\/j.biopha.2026.119847_bib9","doi-asserted-by":"crossref","first-page":"14680","DOI":"10.3390\/ijms232314680","article-title":"The Protective Role of Apelin in the Early Stages of Diabetic Retinopathy","volume":"23","author":"Feng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3892\/ijmm.2026.5832","article-title":"Context\u2011dependent duality of the apelin\/elabela\u2011APJ system in diabetes and its complications (Review)","volume":"57","author":"Han","year":"2026","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119847_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","article-title":"The retina as a window to the brain-from eye research to CNS disorders","author":"London","year":"2013","journal-title":"Nat. Rev. Neurol. Engl."},{"key":"10.1016\/j.biopha.2026.119847_bib12","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol. U. S."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib13","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1038\/s41467-024-50309-w","article-title":"Eye-brain connections revealed by multimodal retinal and brain imaging genetics","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119847_bib14","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1038\/s41467-019-12242-1","article-title":"Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease","author":"Hadoux","year":"2019","journal-title":"Nat. Commun. Engl."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119847_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"O'Dowd","year":"1993","journal-title":"Gene"},{"issue":"6323","key":"10.1016\/j.biopha.2026.119847_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/351233a0","article-title":"Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor","volume":"351","author":"Murphy","year":"1991","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","article-title":"B.F. O'Dowd, Characterization of apelin, the ligand for the APJ receptor","volume":"74","author":"Lee","year":"2000","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1139\/bcb-2014-0072","article-title":"The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR","volume":"92","author":"Chapman","year":"2014","journal-title":"Biochem. Cell. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119847_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.yexcr.2014.08.035","article-title":"Dynamics of apelin receptor\/G protein coupling in living cells","volume":"328","author":"Bai","year":"2014","journal-title":"Exp. Cell. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55381-w","article-title":"Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptor","volume":"15","author":"Williams","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib21","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.1038\/s41467-025-62870-z","article-title":"Mechanistic insights into the versatile stoichiometry and biased signaling of the apelin receptor-arrestin complex","volume":"16","author":"Yue","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119847_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","journal-title":"Dev. Cell."},{"issue":"2-3","key":"10.1016\/j.biopha.2026.119847_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0167-4889(00)00143-9","article-title":"Molecular properties of apelin: tissue distribution and receptor binding","volume":"1538","author":"Kawamata","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2026.119847_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170697","article-title":"Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists","volume":"147","author":"de Oliveira","year":"2022","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2026.119847_bib26","article-title":"The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles","author":"Jiang","year":"2021","journal-title":"Front. Pharmacol. Switz."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2013.07.006","article-title":"Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma","volume":"442","author":"Zhen","year":"2013","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-4889(99)00114-7","article-title":"Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum","volume":"1452","author":"Habata","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"issue":"28","key":"10.1016\/j.biopha.2026.119847_bib29","doi-asserted-by":"crossref","first-page":"21061","DOI":"10.1074\/jbc.M908417199","article-title":"Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin","volume":"275","author":"Hosoya","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119847_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12551-023-01044-x","article-title":"Structure-function relationship and physiological role of apelin and its G protein coupled receptor","author":"Murali","year":"2023","journal-title":"Biophys. Rev. Ger."},{"key":"10.1016\/j.biopha.2026.119847_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101629","article-title":"Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction","volume":"36","author":"Chen","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0167-4781(00)00072-5","article-title":"Distribution of mRNA encoding B78\/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues","volume":"1492","author":"O'Carroll","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2026.119847_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9170480","article-title":"Apelin in Reproductive Physiology and Pathology of Different Species: A Critical Review","volume":"2018","author":"Kurowska","year":"2018","journal-title":"Int. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119847_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","article-title":"Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility","volume":"91","author":"Szokodi","year":"2002","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119847_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","article-title":"Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells","volume":"118","author":"Kleinz","year":"2004","journal-title":"Regul. Pept."},{"issue":"7","key":"10.1016\/j.biopha.2026.119847_bib36","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1002\/jcp.26339","article-title":"Apelin\/APJ system: A critical regulator of vascular smooth muscle cell","volume":"233","author":"Luo","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119847_bib37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cardiores.2007.02.002","article-title":"Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice","volume":"74","author":"Zhong","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.biopha.2026.119847_bib38","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/blood-2014-05-578781","article-title":"Apelin: an antithrombotic factor that inhibits platelet function","volume":"127","author":"Adam","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.biopha.2026.119847_bib39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacc.2008.06.013","article-title":"Vascular effects of apelin in vivo in man","volume":"52","author":"Japp","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2026.119847_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170642","article-title":"vitro metabolism of synthetic Elabela\/Toddler (ELA-32) peptide in human plasma and kidney homogenates analyzed with mass spectrometry and validation of endogenous peptide quantification in tissues by ELISA","volume":"145","author":"Nyimanu","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2026.119847_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109991","article-title":"Apelin-13, a regulator of autophagy, apoptosis and inflammation in multifaceted bone protection","volume":"117","author":"Gong","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119847_bib42","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1167\/iovs.09-4466","article-title":"Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy","volume":"51","author":"Tao","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119847_bib43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.diabres.2012.09.045","article-title":"Apelin-13 regulates proliferation, migration and survival of retinal Muller cells under hypoxia","volume":"99","author":"Lu","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.biopha.2026.119847_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbrc.2004.10.042","article-title":"Apelin is a novel angiogenic factor in retinal endothelial cells","volume":"325","author":"Kasai","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib45","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1167\/iovs.13-11611","article-title":"Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system","volume":"54","author":"Hara","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119847_bib46","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1161\/ATVBAHA.110.209775","article-title":"Apelin is a crucial factor for hypoxia-induced retinal angiogenesis","volume":"30","author":"Kasai","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119847_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ki.2008.199","article-title":"Effect of apelin on glomerular hemodynamic function in the rat kidney","volume":"74","author":"Hus-Citharel","year":"2008","journal-title":"Kidney Int."},{"issue":"28","key":"10.1016\/j.biopha.2026.119847_bib48","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1073\/pnas.0403518101","article-title":"Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release","volume":"101","author":"De Mota","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2026.119847_bib49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2016.08.036","article-title":"Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice","volume":"791","author":"Sakamoto","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119847_bib50","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101785RRR","article-title":"Elabela promotes the retinal angiogenesis by inhibiting ferroptosis during the vaso-obliteration phase in mouse oxygen-induced retinopathy model","volume":"36","author":"Wang","year":"2022","journal-title":"FASEB J."},{"issue":"2-3","key":"10.1016\/j.biopha.2026.119847_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0167-0115(01)00236-1","article-title":"The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism","volume":"99","author":"Tatemoto","year":"2001","journal-title":"Regul. Pept."},{"issue":"10","key":"10.1016\/j.biopha.2026.119847_bib52","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.peptides.2007.07.016","article-title":"Apelin activates L-arginine\/nitric oxide synthase\/nitric oxide pathway in rat aortas","volume":"28","author":"Jia","year":"2007","journal-title":"Peptides"},{"issue":"8","key":"10.1016\/j.biopha.2026.119847_bib53","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1002\/jcp.27942","article-title":"Apelin\/APJ system: A potential therapeutic target for endothelial dysfunction-related diseases","volume":"234","author":"Cheng","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"18","key":"10.1016\/j.biopha.2026.119847_bib54","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1093\/eurheartj\/ehr389","article-title":"Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1","volume":"33","author":"Pchejetski","year":"2012","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib55","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.peptides.2009.02.010","article-title":"Apelin protects heart against ischemia\/reperfusion injury in rat","volume":"30","author":"Zeng","year":"2009","journal-title":"Peptides"},{"issue":"12","key":"10.1016\/j.biopha.2026.119847_bib56","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1089\/dna.2016.3391","article-title":"Apelin\/APJ System: A Novel Therapeutic Target for Myocardial Ischemia\/Reperfusion Injury","volume":"35","author":"Chen","year":"2016","journal-title":"DNA Cell. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119847_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2026.100130","article-title":"International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applications","volume":"78","author":"Davenport","year":"2026","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2026.119847_bib58","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1471-4159.2001.00320.x","article-title":"Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain","volume":"77","author":"Reaux","year":"2001","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.biopha.2026.119847_bib59","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2826.2003.01044.x","article-title":"Regulation of rat APJ receptor messenger ribonucleic acid expression in magnocellular neurones of the paraventricular and supraopric nuclei by osmotic stimuli","volume":"15","author":"O'Carroll","year":"2003","journal-title":"J. Neuroendocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib60","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/138161212799277770","article-title":"Apelin in the control of body fluid homeostasis and cardiovascular functions","volume":"18","author":"Galanth","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2026.119847_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.peptides.2013.03.024","article-title":"Regulation of feeding behavior, gastrointestinal function and fluid homeostasis by apelin","volume":"44","author":"Lv","year":"2013","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib62","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1471-4159.2007.04645.x","article-title":"Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury","volume":"102","author":"O'Donnell","year":"2007","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.biopha.2026.119847_bib63","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.yexcr.2010.02.005","article-title":"Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons","volume":"316","author":"Zeng","year":"2010","journal-title":"Exp. Cell. Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119847_bib64","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s11033-022-08075-9","article-title":"Apelin\/APJ system: an emerging therapeutic target for neurological diseases","volume":"50","author":"Li","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2026.119847_bib65","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1378\/chest.14-1426","article-title":"The Apelin-APJ axis is an endogenous counterinjury mechanism in experimental acute lung injury","volume":"147","author":"Fan","year":"2015","journal-title":"Chest"},{"issue":"15","key":"10.1016\/j.biopha.2026.119847_bib66","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1007\/s00018-020-03461-7","article-title":"Apelin\/APJ system: an emerging therapeutic target for respiratory diseases","volume":"77","author":"Yan","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119847_bib67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000460261","article-title":"Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4","volume":"44","author":"Chu","year":"2017","journal-title":"Cerebrovasc. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2026.119847_bib68","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.drudis.2022.05.004","article-title":"APJ\/apelin: A promising target for the treatment of retinopathy of prematurity","volume":"27","author":"Su","year":"2022","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.biopha.2026.119847_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1646806","article-title":"Faricimab for retinal vein occlusion: a review of current evidence and future perspectives","volume":"16","author":"Jing","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119847_bib70","article-title":"Apelin Protects Primary Rat Retinal Pericytes from Chemical Hypoxia-Induced Apoptosis","author":"Chen","year":"2015","journal-title":"J. Ophthalmol. 2015"},{"issue":"4","key":"10.1016\/j.biopha.2026.119847_bib71","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"M\u00fcller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jphs.2016.12.002","article-title":"Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1\/2, and suppressing TNF-alpha expression in mice","volume":"133","author":"Ishimaru","year":"2017","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib73","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ajpath.2011.09.035","article-title":"Apelin is required for non-neovascular remodeling in the retina","volume":"180","author":"McKenzie","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119847_bib74","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11064-019-02948-5","article-title":"Systemic Administration of an Apelin Receptor Agonist Prevents NMDA-Induced Loss of Retinal Neuronal Cells in Mice","volume":"45","author":"Shibagaki","year":"2020","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10735-024-10279-1","article-title":"Protective effect of Apelin-13 on oxygen and glucose deprivation induced-damage in retinal ganglion cells cultured in vitro","volume":"56","author":"Dai","year":"2024","journal-title":"J. Mol. Histol."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119847_bib76","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0925-4773(01)00558-5","article-title":"Expression of the murine msr\/apj receptor and its ligand apelin is upregulated during formation of the retinal vessels","volume":"110","author":"Saint-Geniez","year":"2002","journal-title":"Mech. Dev."},{"issue":"10","key":"10.1016\/j.biopha.2026.119847_bib77","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.108.174847","article-title":"Apelin-APJ signaling in retinal angiogenesis","volume":"28","author":"Kojima","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119847_bib78","first-page":"1104","article-title":"Apelin is essential for the development of laser-induced choroidal neovascularization model","volume":"10","author":"Jiao","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119847_bib79","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/ATVBAHA.108.163402","article-title":"Retardation of retinal vascular development in apelin-deficient mice","volume":"28","author":"Kasai","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15602-3","article-title":"An apelin receptor antagonist prevents pathological retinal angiogenesis with ischemic retinopathy in mice","volume":"7","author":"Ishimaru","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2026.119847_bib81","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/CIRCRESAHA.108.179333","article-title":"Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis","volume":"103","author":"Eyries","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2026.119847_bib82","article-title":"The Role of Apelin-APJ System in Diabetes and Obesity","volume":"13","author":"Li","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"9735","key":"10.1016\/j.biopha.2026.119847_bib83","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib84","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cmet.2012.11.012","article-title":"Vascular complications of diabetes: mechanisms of injury and protective factors","volume":"17","author":"Rask-Madsen","year":"2013","journal-title":"Cell. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib85","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12886-020-01593-9","article-title":"VEGF, apelin and HO-1 in diabetic patients with retinopathy: a correlation analysis","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Ophthalmol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib86","first-page":"968","article-title":"Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients","volume":"7","author":"Du","year":"2014","journal-title":"Int. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119847_bib87","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/2090-0686.131587","article-title":"Evaluation of the role of apelin in diabetic retinopathy","volume":"106","author":"Nada","year":"2013","journal-title":"J. Egypt. Ophthalmol. Soc."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib88","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12886-017-0556-6","article-title":"Apln-CreERT:mT\/mG reporter mice as a tool for sprouting angiogenesis study","volume":"17","author":"Pi","year":"2017","journal-title":"BMC Ophthalmol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119847_bib89","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10456-013-9349-6","article-title":"Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis","volume":"16","author":"Kasai","year":"2013","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib90","doi-asserted-by":"crossref","first-page":"17267","DOI":"10.1038\/s41598-023-44639-w","article-title":"Protamine as a barrier against the angiogenic effect of insulin: a possible role of apelin","volume":"13","author":"Yeganeh-Hajahmadi","year":"2023","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2026.119847_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069703","article-title":"The role of apelin in the retina of diabetic rats","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib92","doi-asserted-by":"crossref","DOI":"10.1080\/08916934.2023.2259129","article-title":"Effects of Apelin on the fibrosis of retinal tissues and Muller cells in diabetes retinopathy through the JAK2\/STAT3 signalling pathway","volume":"56","author":"Li","year":"2023","journal-title":"Autoimmunity"},{"key":"10.1016\/j.biopha.2026.119847_bib93","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18841","article-title":"The potential of serum elabela levels as a marker of diabetic retinopathy: results from a pilot cross-sectional study","volume":"13","author":"Seyithanoglu","year":"2025","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib94","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10989-025-10794-z","article-title":"ELABELA in Diabetes and Related Diseases: A Multifaceted Regulator of Inflammation, Oxidative Stress, and Organ Protection","volume":"32","author":"Zhu","year":"2025","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119847_bib95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum. Dev."},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib96","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1111\/aos.13297","article-title":"Vascular endothelial growth factor and apelin in plasma of patients with retinopathy of prematurity","volume":"95","author":"Feng","year":"2017","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib97","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12886-022-02565-x","article-title":"Correlation between apelin and VEGF levels in retinopathy of prematurity: a matched case-control study","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Ophthalmol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib98","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2217\/bmm.12.82","article-title":"Correlation between cord blood apelin and IGF-1 levels in retinopathy of prematurity","volume":"6","author":"Cekmez","year":"2012","journal-title":"Biomark. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib99","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000528358","article-title":"Plasma Level of Apelin as a Promising Factor for Retinopathy of Prematurity","volume":"66","author":"Feng","year":"2023","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.biopha.2026.119847_bib100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/OPTH.S127943","article-title":"The role of serum apelin in retinopathy of prematurity","volume":"11","author":"Ali","year":"2017","journal-title":"Clin. Ophthalmol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119847_bib101","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3390\/biomedicines12091937","article-title":"Animal Models of Retinopathy of Prematurity: Advances and Metabolic Regulators","volume":"12","author":"Maurya","year":"2024","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.biopha.2026.119847_bib102","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1167\/iovs.61.8.47","article-title":"The Role of Apelin\/APJ in a Mouse Model of Oxygen-induced Retinopathy","volume":"61","author":"Feng","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119847_bib103","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1002\/jcb.26473","article-title":"Effects of apelin on retinal microglial cells in a rat model of oxygen-induced retinopathy of prematurity","volume":"119","author":"Zhang","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.biopha.2026.119847_bib104","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1016\/j.ajpath.2014.07.012","article-title":"Activation of the endothelin system mediates pathological angiogenesis during ischemic retinopathy","volume":"184","author":"Patel","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2026.119847_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109347","article-title":"Ferrostatin-1 attenuates pathological angiogenesis in oxygen-induced retinopathy via inhibition of ferroptosis","volume":"226","author":"Liu","year":"2023","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119847_bib106","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/path.4266","article-title":"Mechanisms of age-related macular degeneration and therapeutic opportunities","volume":"232","author":"van Lookeren Campagne","year":"2014","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119847_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166340","article-title":"Comparative transcriptome analysis of human and murine choroidal neovascularization identifies fibroblast growth factor inducible-14 as phylogenetically conserved mediator of neovascular age-related macular degeneration","volume":"1868","author":"Wolf","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2026.119847_bib108","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3389\/fcell.2020.00808","article-title":"Integrated Microarray and RNAseq Transcriptomic Analysis of Retinal Pigment Epithelium\/Choroid in Age-Related Macular Degeneration","volume":"8","author":"Dhirachaikulpanich","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"issue":"13","key":"10.1016\/j.biopha.2026.119847_bib109","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1167\/iovs.64.13.40","article-title":"Gene Expression Within a Human Choroidal Neovascular Membrane Using Spatial Transcriptomics","volume":"64","author":"Voigt","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2026.119847_bib110","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1210\/en.2004-1427","article-title":"Apelin, a newly identified adipokine up-regulated by insulin and obesity","author":"Boucher","year":"2005","journal-title":"Endocrinol. U. S."},{"key":"10.1016\/j.biopha.2026.119847_bib111","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.43401","article-title":"Study of Serum Apelin and Insulin Resistance in Type 2 Diabetes Mellitus Patients With or Without Obesity","author":"Mund","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2026.119847_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2025.100365","article-title":"The potential role of adipokines and hepatokines in age-related ocular diseases","author":"Almpanidou","year":"2025","journal-title":"Metabol. Open. Engl."},{"key":"10.1016\/j.biopha.2026.119847_bib113","doi-asserted-by":"crossref","first-page":"14982","DOI":"10.3390\/ijms232314982","article-title":"The Role of Adipokines in Inflammatory Mechanisms of Obesity","author":"Kirichenko","year":"2022","journal-title":"Int. J. Mol. Sci. Switz."},{"key":"10.1016\/j.biopha.2026.119847_bib114","article-title":"Angiogenesis in Adipose Tissue: The Interplay Between Adipose and Endothelial Cells","volume":"11","author":"Herold","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2026.119847_bib115","doi-asserted-by":"crossref","DOI":"10.2196\/48120","article-title":"Association of Visceral Obesity Indices With Incident Diabetic Retinopathy in Patients With Diabetes: Prospective Cohort Study","author":"Chen","year":"2024","journal-title":"JMIR Public. Health Surveill. Can."},{"key":"10.1016\/j.biopha.2026.119847_bib116","doi-asserted-by":"crossref","first-page":"04164","DOI":"10.7189\/jogh.15.04164","article-title":"Childhood obesity directly increases age-related macular degeneration risk: the role of physiobiological and immune-metabolic function","author":"Zhang","year":"2025","journal-title":"J. Glob. Health Scotl."},{"key":"10.1016\/j.biopha.2026.119847_bib117","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.3390\/ijms24032036","article-title":"The Correlation between Waist Circumference and the Pro-Inflammatory Adipokines in Diabetic Retinopathy of Type 2 Diabetes Patients","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci. Switz."},{"key":"10.1016\/j.biopha.2026.119847_bib118","doi-asserted-by":"crossref","first-page":"8498","DOI":"10.1038\/s41598-025-93562-9","article-title":"Association of serum adiponectin and leptin levels with inner retinal thickness among individuals with or without elevated HbA1c","author":"Koseoglu","year":"2025","journal-title":"Sci. Rep. Engl."},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib119","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12616","article-title":"Shedding light on eye disease in obesity: A review","volume":"14","author":"Lam","year":"2024","journal-title":"Clin. Obes."},{"issue":"9","key":"10.1016\/j.biopha.2026.119847_bib120","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/s41366-021-00829-y","article-title":"Obesity and risk of age-related eye diseases: a systematic review of prospective population-based studies","volume":"45","author":"Ng Yin Ling","year":"2021","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2026.119847_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111278","article-title":"The therapeutic potentials of apelin in obesity-associated diseases","volume":"529","author":"Castan-Laurell","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119847_bib122","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1111\/aos.14954","article-title":"Diagnostic circulating biomarkers to detect vision-threatening diabetic retinopathy: Potential screening tool of the future?","volume":"100","author":"Frudd","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.biopha.2026.119847_bib123","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fnagi.2020.00058","article-title":"Endogenous Apelin Is Protective Against Age-Associated Loss of Retinal Ganglion Cells in Mice","volume":"12","author":"Ishimaru","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biopha.2026.119847_bib124","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000513050","article-title":"Apelin-13: A Promising Biomarker for Age-Related Macular Degeneration?","author":"Vural","year":"2021","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.biopha.2026.119847_bib125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bjo.2007.122283","article-title":"Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy","volume":"92","author":"Gomi","year":"2008","journal-title":"Br. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119847_bib126","article-title":"Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization","volume":"13","author":"Chen","year":"2018","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.biopha.2026.119847_bib127","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/jpet.300.2.399","article-title":"Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate","volume":"300","author":"Li","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2026.119847_bib128","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.icu.0000143688.45232.15","article-title":"Drug-induced corneal complications","volume":"15","author":"Hollander","year":"2004","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119847_bib129","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1358\/dnp.2002.15.4.840055","article-title":"Diabetic Retinopathy and the NMDA Receptor","volume":"15","author":"Smith","year":"2002","journal-title":"Drug. N. Perspect."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:05:50Z","timestamp":1790082350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":129,"alternative-id":["S0753332226008838"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119847","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The apelin\/APJ signaling axis in ocular neurovascular disorders: Molecular mechanisms and therapeutic strategies for angiogenesis and neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119847"}}